Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Alzheimer's Disease

  Free Subscription


Articles published in Nervenarzt

Retrieve available abstracts of 17 articles:
HTML format



Single Articles


    February 2024
  1. HAUSSMANN R, Homeyer P, Haussmann M, Sauer C, et al
    [Analysis of the prevalence of anticoagulant therapy in patients with cognitive disorders and cerebral amyloid angiopathy (CAA)].
    Nervenarzt. 2024;95:146-151.
    PubMed     Abstract available


    October 2023
  2. VOGLEIN J, Levin J, Hoglinger G
    [Treatment-Quo vadis neurodegeneration?].
    Nervenarzt. 2023;94:904-912.
    PubMed     Abstract available


    September 2023
  3. BARTSCH T, Berg D, Heneka M, Leypoldt F, et al
    [Parkinson's and Alzheimer's disease as system-wide neurodegenerative disorders].
    Nervenarzt. 2023 Sep 6. doi: 10.1007/s00115-023-01542.
    PubMed     Abstract available


    August 2023
  4. SCHAFFER E, Piel J
    [The exposome in the context of preventive measures for Alzheimer's and Parkinson's diseases].
    Nervenarzt. 2023 Aug 28. doi: 10.1007/s00115-023-01538.
    PubMed     Abstract available


    July 2023
  5. JESSEN F, Bohr L, Kruse C, Dodel R, et al
    [The German S3 guidelines on dementia].
    Nervenarzt. 2023;94:609-613.
    PubMed     Abstract available


    April 2023
  6. DUZEL E, Thyrian JR
    [Mobile everyday-life digital technologies for the prevention of Alzheimer's dementia: cognitive health and cognitive safety].
    Nervenarzt. 2023 Apr 28. doi: 10.1007/s00115-023-01478.
    PubMed     Abstract available


    March 2023
  7. ZEYEN P, Sannemann L, Bohr L, Escher C, et al
    [Brain health services: individual dementia risk profiling at the Cologne Alzheimer Prevention Center].
    Nervenarzt. 2023 Mar 7. doi: 10.1007/s00115-023-01451.
    PubMed     Abstract available


    December 2022
  8. HAUSSMANN R, Homeyer P, Brandt MD, Donix M, et al
    [Prognostic and diagnostic value of cerebrospinal fluid analysis in neurodegenerative dementia diseases].
    Nervenarzt. 2022;93:1236-1242.
    PubMed     Abstract available


    August 2022
  9. FROLICH L, Hausner L
    [Erratum to: Disease-modifying treatment approaches for Alzheimer's disease].
    Nervenarzt. 2022 Aug 12. pii: 10.1007/s00115-022-01366.
    PubMed    


    March 2022
  10. HAGER K
    [Alzheimer's disease-Which substances are at present in phase III studies?]
    Nervenarzt. 2022 Mar 14. pii: 10.1007/s00115-022-01275.
    PubMed     Abstract available


    December 2021
  11. RESPONDEK G, Krey L, Huber M, Pflugrad H, et al
    [Neuroprotective treatment of tauopathies].
    Nervenarzt. 2021;92:1227-1238.
    PubMed     Abstract available


    November 2021
  12. FROLICH L, Hausner L
    [Disease-modifying treatment approaches for Alzheimer's disease].
    Nervenarzt. 2021 Nov 4. pii: 10.1007/s00115-021-01222.
    PubMed     Abstract available


    October 2021
  13. HAUSSMANN R, Homeyer P, Donix M, Linn J, et al
    [Current findings on the coincidence of cerebral amyloid angiopathy and Alzheimer's disease].
    Nervenarzt. 2021 Oct 15. pii: 10.1007/s00115-021-01213.
    PubMed     Abstract available


    September 2021
  14. HAGER K
    [First causally effective drug against Alzheimer's? : The FDA approves aducanumab].
    Nervenarzt. 2021 Sep 7. pii: 10.1007/s00115-021-01182.
    PubMed    


    February 2021
  15. HAUSSMANN R, Krug C, Noppes F, Brandt M, et al
    [Criminal behavior in frontotemporal dementia and Alzheimer's disease].
    Nervenarzt. 2021 Feb 11. pii: 10.1007/s00115-021-01070.
    PubMed     Abstract available


    December 2020
  16. FORSTL H
    [Catatonic walks with Emil Kraepelin, Aloys Alzheimer, Henry Aloysius Cotton and others].
    Nervenarzt. 2020 Dec 16. pii: 10.1007/s00115-020-01039.
    PubMed     Abstract available


    October 2020
  17. PAWLOWSKI M, Johnen A, Duning T
    [Young onset dementia].
    Nervenarzt. 2020;91:936-945.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.